1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
OpenText said it will buy up to $300,000,000 of its 3.875% Senior Notes due 2028 in a cash tender offer, but holders tendered $697,563,000, so purchases are prorated at 43.047752%. The company expects a concurrent senior secured notes offering to close on October 1, 2026, with proceeds and cash on hand used to redeem its 6.900% Senior Secured Notes due 2027 and to pay for the tendered 2028 notes. The filing concerns debt refinancing and does not report earnings or guidance.
Accepts up to $300,000,000 aggregate principal; $697,563,000 principal tendered; proration factor 43.047752%.
Tender Offer Consideration of $981.71 per $1,000 principal, set at a fixed spread of +50 basis points over the 4.250% U.S. Treasury due February 15, 2028 (reference yield 4.773%).
Tender expired 5:00 p.m. New York City time on September 30, 2026; settlement expected October 2, 2026.
Concurrent senior secured notes offering expected to close October 1, 2026, to fund the redemption of the 6.900% Senior Secured Notes due 2027.
Sagimet Biosciences agreed on September 30, 2026 to sell 8,750,010 shares of Series A common stock at $10.00 per share and pre-funded warrants for up to 2,750,010 shares, with net proceeds expected to be $107.5 million. The company plans to use the proceeds with its existing cash to fund a Phase 3 trial of denifanstat in acne, pre-launch activities, and other clinical and corporate needs, and the offering is expected to close on October 1, 2026.
8,750,010 common shares offered at $10.00 per share, plus pre-funded warrants for up to 2,750,010 shares
Expected net proceeds of $107.5 million after underwriting discounts and commissions
Offering expected to close October 1, 2026, subject to customary closing conditions
Underwriters include Leerink Partners LLC, TD Securities (USA) LLC and Guggenheim Securities, LLC as representatives
On September 30, 2026, Solana Company agreed to sell 4,369,356 Class A shares at $3.433 each to a single institutional investor, with warrants for the same number of shares at $3.776. Gross proceeds are expected to be about $15 million, or about $14.3 million net, and the offering is expected to close on or about October 1, 2026. The issuance adds new shares that existing shareholders will share in, and the company plans to use the proceeds to accumulate SOL, buy back stock, and for working capital and other purposes.
4,369,356 Class A shares sold at $3.433 per share, with warrants for up to 4,369,356 shares at $3.776 per share
Gross proceeds about $15 million; net proceeds about $14.3 million; placement agent cash fee of 4.0% of gross proceeds
Shares priced at a 5% premium to net asset value per share; company reported total NAV of $278 million as of September 24, 2026, with SOL at $119
Closing expected on or about October 1, 2026; Clear Street served as exclusive placement agent
Cheetah Net Supply Chain Service Inc. disclosed progress on its at-the-market share sale program with Pacific Century Securities, which allows sales of Class A common stock of up to $35.3 million. As of September 25, 2026, the company had sold about 196,850,000 shares under the program, before the reverse split took effect on September 28, 2026. After the 1-for-150 reverse split, the company reports about 1,332,087 Class A and 1,358 Class B shares outstanding, a much smaller share count for existing holders.
ATM Offering authorizes sales of Class A common stock with an aggregate offering price of up to $35.3 million, under an agreement entered August 21, 2026
About 196,850,000 shares sold under the ATM Offering as of September 25, 2026, before giving effect to the reverse split
1-for-150 reverse split of Class A and Class B common stock became market effective September 28, 2026
After the split, about 1,332,087 Class A and 1,358 Class B shares are issued and outstanding
Immix Biopharma agreed on September 29, 2026 to sell 11,363,637 shares of common stock at $11.00 per share in an underwritten offering led by J.P. Morgan Securities LLC. The company expects gross proceeds of $125 million and net proceeds of approximately $117.1 million, with closing expected on September 30, 2026. The company plans to use the proceeds for NXC-201 development, working capital and general corporate purposes.
11,363,637 shares priced at $11.00 per share under an underwriting agreement with J.P. Morgan Securities LLC dated September 29, 2026
Expected gross proceeds of $125 million and net proceeds of approximately $117.1 million after underwriting discounts, commissions and offering expenses
Offering expected to close on or about September 30, 2026, subject to customary conditions; proceeds to fund NXC-201 development, working capital and general corporate purposes
CTO Realty Growth entered into a $1.0 billion amended and restated unsecured credit agreement with KeyBank as administrative agent, dated September 29, 2026, replacing its prior facility. Proceeds repaid its previous $300 million revolving credit facility and two term loans of $100 million each due in January 2027 and January 2028. The company says the deal extends debt maturities to 2029 through 2032 and adds $250 million of commitments, which lengthens its weighted average debt maturity to 4.3 years from 1.6 years, excluding extension options.
Facilities total $1.0 billion: a $400 million revolver due September 2030 with two six-month extension options, plus four $150 million term loans due September 2029, September 2030, September 2031 and March 2032
Total commitments increase by $250 million, with an accordion feature allowing up to $1.5 billion in aggregate commitments
Initial fixed rates after SOFR swaps are 5.3% (2029 loan), 4.9% (2030 loan), 4.8% (2031 loan) and 3.4% (2032 loan), with the 2032 rate adjusting to about 5.3% in February 2027
Company is subject to customary restrictive covenants and financial maintenance covenants
Burke & Herbert Financial Services Corp. completed a $100 million public offering of 7.00% fixed-to-floating rate subordinated notes due October 1, 2036, with the offering priced at 100% of principal. The company plans to use the proceeds, plus cash on hand, to repay several existing subordinated notes and potentially redeem part of its 2021 Preferred Stock, and to provide capital to its bank subsidiary.
$100.0 million of 7.00% fixed-to-floating rate subordinated notes due October 1, 2036, sold at 100% of principal through Keefe, Bruyette & Woods, Inc.
Fixed 7.00% interest until October 1, 2031, then floating at Three-Month Term SOFR plus 222 basis points
Proceeds plus cash on hand earmarked to repay $4.5 million 2028 note, $18.1 million July 2030 notes and $20.0 million October 2030 notes, and potentially repay $75.0 million of 3.25% notes due 2031
Offering expected to close September 30, 2026; notes intended to qualify as Tier 2 capital
On September 30, 2026, Vroom Automotive, LLC, a Vroom subsidiary, issued 16,000 Series A1 and 4,000 Series B1 preferred units to SPE Holdings 2026-1 for $20 million in gross proceeds. The units carry quarterly preferential distributions tied to SOFR plus 8.50% or 9.25%, and the Series B1 units are convertible into common units of Vroom Automotive at SPE Holdings' option. Vroom Automotive expects to use the proceeds to repay certain obligations and to purchase residual interests in certain asset-backed securitization trusts.
Gross proceeds of $20,000,000 from 16,000 Series A1 and 4,000 Series B1 preferred units
Distribution rate resets quarterly at 90-day average SOFR plus 8.50% (Series A1) or 9.25% (Series B1)
Series B1 units are convertible into common units at SPE Holdings' option; Series A1 units are not convertible
Agreement and A&R LLC Agreement dated September 30, 2026, filed as exhibits 10.1 and 10.2
Sonoco Products entered into a first amendment to its credit agreement on September 25, 2026, adding two term loan facilities totaling $800 million. It borrowed $500 million on the closing date and used it to refinance an existing $500 million term loan that was due in August 2028, with the remaining $300 million available for future refinancings.
New $400 million Tranche A term loan matures December 31, 2029, with no scheduled payments before maturity
New $400 million Tranche B delayed-draw term loan matures December 31, 2031; $100 million drawn at closing and $300 million remaining
$500 million borrowed on September 25, 2026 refinances an existing $500 million syndicated term loan scheduled to mature in August 2028
Interest margins are tied to senior unsecured debt ratings from S&P and/or Moody's
TD SYNNEX amended its trade receivables securitization program on September 25, 2026, extending the maturity to September 25, 2028 and raising lender commitments to $3.0 billion. The filing also lowers the program fee rates on used commitments to 0.725% (commercial paper funded) and 0.825% (other funding), and the lenders received an upfront fee.
Maturity extended to September 25, 2028
Aggregate lender commitment increased to $3,000,000,000
Program fee on used portion set at 0.725% per annum for commercial paper funding and 0.825% for other funding
Lenders were paid an upfront fee; the filing does not state its amount
Digimarc agreed on September 29, 2026 to sell 4,500,000 common shares at $4.04 per share in a registered direct offering, with gross proceeds expected to be about $18.2 million and closing expected on or about September 30, 2026. The company plans to use the net proceeds for general corporate purposes, and the filing adds investor participation rights in future equity offerings and a limit on most new share issuance through December 31, 2026, which shareholders should weigh alongside the new share count.
4,500,000 common shares offered at $4.04 per share; gross proceeds expected to be about $18.2 million
Closing expected on or about September 30, 2026, subject to customary closing conditions
Needham & Company acted as sole placement agent; shares sold under an S-3 registration statement declared effective July 13, 2026
Investors get participation rights in future equity offerings until the earlier of the third anniversary of closing or when the two most recent quarters show positive EBIT and operating cash flow
Rent the Runway launched a $15 million rights offering on September 30, 2026, giving eligible Class A stockholders the right to buy additional shares. Holders who keep their shares can use the rights to buy shares at $3.55 each, and the rights expire on October 14, 2026 unless extended.
Rights offering size: $15 million, launched September 30, 2026
Record date: 5:00 p.m. New York City time on September 25, 2026; each share held received one right
Each right entitles the holder to buy approximately 0.1251 Class A shares at $3.55 per share; no fractional shares will be issued
Rights expire at 5:00 p.m. New York City time on October 14, 2026, unless extended
Indaptus Therapeutics agreed on September 29, 2026 to extend the outside date for the closing of its $24.0 million private placement of common stock from September 29 to October 16, 2026. The notices and consents also let the company defer closing until purchaser closing conditions are met or waived, and extend the purchasers' funding deadline and related termination rights to the same date. For shareholders, the filing shows the financing has not yet closed and its timing now depends on the extended deadline.
Private placement of common stock with aggregate gross proceeds of approximately $24.0 million, before offering expenses, agreed on September 8, 2026
Outside date extended from September 29, 2026 to October 16, 2026 for each purchaser
Company may defer closing until purchaser closing conditions are satisfied or waived, but no later than October 16, 2026, unless otherwise agreed in writing
All other terms of the Purchase Agreement remain unchanged
Trump Media & Technology Group (TMTG) and TAE Technologies signed an amended and restated convertible promissory note that replaces a December 18, 2025 note tied to their pending all-stock merger. The amended note carries an initial $200 million first tranche, allows up to an additional $100 million second tranche, and caps total principal at $300 million plus PIK interest, so TMTG's financial exposure to TAE rises if the second tranche is drawn. The companies also filed a Form S-4 registration statement for the merger, which has not yet become effective.
First tranche principal is $200 million; TAE may request up to $100 million more during a second tranche draw period.
Second tranche draw period ends on the earlier of November 29, 2026 or termination of the merger agreement; each drawdown must be at least $50 million.
Interest accrues at 7% per year and is paid in kind by adding to principal; accrued interest under the note was $10,969,863.01 as of signing.
The note converts automatically on a qualified TAE financing of at least $300 million, and TMTG gets pre-conversion voting rights tied to 25% of the outstanding amount.
PRA Group priced a $400.0 million offering of 8.500% senior notes due 2033 in a private transaction exempt from Securities Act registration. The company plans to use the net proceeds and available cash to repay approximately $400.0 million of borrowings under its North American revolving credit facility, and the offering is expected to close on or about October 2, 2026.
Priced $400.0 million aggregate principal of 8.500% senior notes due 2033 on September 29, 2026
Expected closing on or about October 2, 2026, subject to customary conditions
Net proceeds and available cash to repay approximately $400.0 million of North American revolving credit facility borrowings
Notes offered to qualified institutional buyers under Rule 144A and certain non-U.S. persons under Regulation S; guaranteed on a senior unsecured basis by domestic subsidiaries
Delek US Holdings completed a private offering of $460 million of 0.00% convertible senior notes due November 1, 2031, including the initial purchasers' option exercised in full. The company received net proceeds of $449.1 million, and it will use part of them to fund capped call transactions and the rest for general corporate purposes, including partial repayment of its term loan. The notes are convertible at about $85.31 per share, and the capped calls are intended to reduce potential dilution to shareholders.
Aggregate principal of $460 million, including the $60 million additional option exercised on September 25, 2026
Net proceeds of $449.1 million after initial purchasers' discounts and commissions
Initial conversion price of about $85.31 per share, a 27.5% premium over the $66.91 closing price on September 24, 2026
Capped call transactions cost about $34.3 million, with a cap price of about $117.09 per share
GEN Restaurant Group entered into a Common Stock Purchase Agreement and Registration Rights Agreement with Roth Principal Investments, LLC, dated September 29, 2026. The company may sell up to $25,000,000 of newly issued Class A common stock to Roth over up to 36 months, at its sole option, once a resale registration statement is declared effective. Issuance of new shares would dilute existing shareholders, and the company is under no obligation to sell any shares.
Facility size: up to $25,000,000 of newly issued Class A common stock, at the company's sole discretion.
Term: up to 36 months beginning on the SEC effective date of the resale registration statement.
Pricing: purchases are priced at a VWAP-based discount of 3.0% for market open and intraday purchases and 5.0% for pre-market and post-market purchases.
Nasdaq rules cap issuance under the agreement at 6,776,399 shares, which the filing says equals 19.99% of Class A common stock.
Vulcan Infrastructure and Power agreed on September 23, 2026 to exchange $2,793,150 in principal of its 8.50% notes due 2026, plus about $40,230 in accrued interest, for new 10.00% senior notes due 2030 and three-year warrants on 1,000,000 Class A shares at $1.87. The company expects the exchange to close on or about October 1, 2026, and the filing does not give any results or cash figures, so the effect on shareholders is limited to the dilution potential of the warrants and the terms of the new debt.
Exchange covers $2,793,150 in 2026 notes plus about $40,230 in accrued interest
Holders receive $2,833,358 in 10.00% senior notes due 2030
Warrants cover 1,000,000 Class A shares at $1.87 per share, exercisable for three years and only for cash
Closing expected on or about October 1, 2026, subject to conditions
BuzzFeed agreed on September 23, 2026 to issue 4,300,000 new Class A shares to Allen Family Digital, LLC, an affiliate of Chairman Byron Allen Folks' family office, at $1.09 per share. The deal raised about $4.7 million and is a related-party transaction approved by the four disinterested directors, with Mr. Folks abstaining.
Shares issued: 4,300,000 newly issued Class A common shares at $1.09 each, priced at the September 22, 2026 Nasdaq closing price
Proceeds: approximately $4.7 million, per the filing
Related party: Purchaser is linked to Chairman Byron Allen Folks, who is also the company's controlling shareholder through the Purchaser; the audit committee approved the deal
Issuance was made under Section 4(a)(2) of the Securities Act, exempt from registration; agreement filed as Exhibit 10.1
On September 29, 2026, Tesla entered into three credit agreements totaling $30.0 billion: a $20.0 billion delayed draw term loan, an $8.0 billion five-year revolver and a $2.0 billion 364-day revolver. The company said no loans were outstanding under the facilities as of that date and that it does not currently plan to draw on them in 2026. The new agreements replaced an existing $5.0 billion revolving credit agreement that was terminated without early termination penalties.
Facilities total $30.0 billion: $20.0 billion term loan, $8.0 billion five-year revolver, $2.0 billion 364-day revolver
No loans were outstanding as of September 29, 2026; Tesla does not currently plan to draw on the facilities in 2026
Credit agreements require at least $5.0 billion of consolidated liquidity
Existing $5.0 billion revolving credit agreement with Citi, due January 20, 2028, was terminated with no borrowings and no early termination penalties
Unitil Corporation entered a Note Purchase Agreement on September 24, 2026, selling $27 million of 5.42% notes due 2031 and $33 million of 5.79% notes due 2036, totaling $60 million. The company plans to use the proceeds to make capital contributions to its utility subsidiaries, refinance existing debt and for general corporate purposes, which adds long-term debt to its balance sheet.
Series 2026A: $27 million of 5.42% senior unsecured notes due September 24, 2031
Series 2026B: $33 million of 5.79% senior unsecured notes due September 24, 2036
Proceeds planned for capital contributions to utility subsidiaries, debt refinancing and general corporate purposes
Notes sold privately to institutional investors under Section 4(a)(2) and are not registered under the Securities Act
Advanced Flower Capital entered into Amendment Number Ten to its Loan and Security Agreement on September 25, 2026. The amendment sets conditions on the advance rate for credit facilities in the borrowing base, revises the loan fee structure, and temporarily raises aggregate revolver commitments to $130 million, with quarterly increases of up to $50 million during set periods. Outside those periods, commitments revert to $80 million, so shareholders should note the facility's capacity is time-limited.
Amendment dated September 25, 2026, to the Loan and Security Agreement originally dated April 29, 2022
Base aggregate revolver commitments of $80 million; temporary increase brings total to up to $130 million during Quarterly Temporary Increase Periods
Quarterly Temporary Increase Amount of up to $50 million; commitments automatically revert to $80 million when the period ends
Full text filed as Exhibit 10.9J; filing signed by CFO and Treasurer Brandon Hetzel on September 29, 2026
Dynex Capital closed its underwritten public offering of 4,800,000 shares of 9.375% Series D Fixed-Rate Cumulative Redeemable Preferred Stock on September 29, 2026, with underwriters holding an option for 720,000 more shares. The Articles of Amendment creating the series took effect the same day, adding a senior class of preferred stock that pays $2.34375 per share annually on a $25.00 liquidation preference.
4,800,000 Series D preferred shares sold in the underwritten offering, plus a 30-day option for up to 720,000 additional shares
Dividends of 9.375% of the $25.00 liquidation preference, or $2.34375 per share per year, payable quarterly starting January 15, 2027
Series D shares cannot be redeemed before October 15, 2031, except in certain tax-related cases or upon a Change of Control
Series C preferred stock (4,460,000 shares outstanding) ranks on parity with the new Series D shares; the Series D shares rank junior to all of the company's debt
Scilex Holding Company amended a promissory note under which it extended an uncommitted revolving credit line to Vivasor, Inc., raising the maximum principal from $20 million to $30 million. The filing states that the Board and the Audit Committee approved the amendment, and that Vivasor is led by Scilex's CEO, Dr. Henry Ji, which makes it a related-party transaction shareholders can assess.
Amendment dated September 25, 2026 raised the maximum aggregate principal of the revolving line of credit from $20,000,000 to $30,000,000.
The original Promissory Note with Vivasor, Inc. was entered into on August 8, 2026; the amendment changed no other terms.
Dr. Henry Ji, Scilex's Chief Executive Officer, President and Chairperson, also serves as Chief Executive Officer of Vivasor.
The Board and the Audit Committee approved the amendment; a copy is filed as Exhibit 10.1.
TELA Bio entered into a Limited Consent to its credit agreement on September 28, 2026, with Perceptive Credit Holdings V, LP, as administrative agent, and the Required Lenders. The consent means the minimum Revenue covenant in Section 10.02 of the credit agreement will not be tested for the quarters ending on or about September 30, 2026 and December 31, 2026. The filing does not state the reason for the consent.
Limited Consent dated September 28, 2026, amending the credit agreement dated November 13, 2025
Minimum Revenue covenant in Section 10.02 not tested for quarters ending on or about September 30, 2026 and December 31, 2026
TransDigm Inc., a subsidiary of TransDigm Group, completed a $3 billion offering of 6.75% senior secured notes maturing January 2035 on September 28, 2026, at 100% of principal. The company plans to use the net proceeds to repurchase $2.1 billion of its 6.75% notes due 2028 through a tender offer and for general corporate purposes, which refinances existing debt and adds new long-term borrowing.
Notes: $3,000 million, 6.75% coupon, issued at 100.00% of principal, maturing January 31, 2035
Interest payable January 31 and July 31 each year, starting January 31, 2027
Proceeds intended to repurchase $2,100 million of 6.75% notes due 2028 via a tender offer launched September 14, 2026, plus general corporate purposes
Indenture dated September 28, 2026 includes covenants limiting additional debt, distributions and asset sales; trustee is The Bank of New York Mellon Trust Company, N.A.
Sherwin-Williams entered a new 364-day, $750 million senior unsecured term loan on September 24, 2026, using it to repay and terminate its existing 364-day credit agreement dated August 8, 2025. Its subsidiary SW Luxembourg also took a new €100 million term loan from ING Bank, guaranteed by Sherwin-Williams, which can help refinance the existing facility. The filing describes these as refinancing and general corporate purposes, and the new loans mature in September 2027.
New $750 million term loan with Citibank, N.A. as administrative agent matures September 23, 2027
Existing 364-day credit agreement dated August 8, 2025 was repaid and terminated effective September 24, 2026
SW Luxembourg obtained a €100 million term loan from ING Bank, guaranteed by Sherwin-Williams, maturing September 23, 2027
New credit agreement requires leverage ratio of no more than 3.75 to 1.00, rising to 4.25 to 1.00 for four quarters after a Qualifying Acquisition
On September 28, 2026, T1 Energy agreed to sell an additional $50.0 million of its 4.75% convertible senior notes due 2031 to an existing shareholder, with closing expected September 30, 2026. The company says the proceeds will fund Phase 1 of its G2_Austin solar cell fab and general corporate purposes, and that the deal is a bridge to a larger financing that includes a significant debt component. For shareholders, it raises total convertible notes outstanding to $170.0 million and could add up to 13,440,860 shares if converted.
Additional principal of $50.0 million; gross proceeds expected to be about $50.4 million including interest accrued from July 31, 2026
Total 4.75% convertible notes due 2031 outstanding rise from $120.0 million to $170.0 million
Initial conversion price of about $4.46 per share; maximum of 13,440,860 shares initially issuable on conversion
Company must file a resale registration statement within 30 calendar days after the September 30, 2026 closing
Viking Therapeutics sold 7,857,143 shares of common stock at $35.00 per share and separately sold $225.0 million of 2.00% convertible senior notes due 2032, with underwriters exercising their options in full. Net proceeds were about $297.0 million from the stock sale and about $250.8 million from the notes, which the company intends to use for its VK2735 and VK3019 programs and general corporate purposes. The stock sale adds shares outstanding for existing shareholders, and the notes add debt that could convert into common stock at about $50.75 per share.
Stock: 7,857,143 shares at $35.00 per share, plus 1,178,571 option shares exercised in full on September 24, 2026; closed September 25, 2026; net proceeds about $297.0 million
Notes: $225.0 million of 2.00% convertible senior notes due October 15, 2032, plus a $33,750,000 option exercised in full on September 24, 2026; net proceeds about $250.8 million
Conversion price about $50.75 per share (19.7044 shares per $1,000 principal); company may settle conversions in cash, shares or a combination
Proceeds intended for VK2735 and VK3019 clinical programs and general corporate purposes
U.S. Physical Therapy entered a 45-month forward-starting interest rate swap with Bank of America on September 22, 2026, with an initial notional amount of $170.6 million. The swap fixes the variable interest rate on the term debt under its April 14, 2026 credit agreement, starting June 30, 2027, when its existing swap expires. The filing describes this as a hedge on borrowing costs, with no earnings figures disclosed.
Swap notional amount: $170.6 million, reflecting term loan amortization as of the effective date
Company pays a fixed rate of 4.578% per annum and receives one-month SOFR; swap effective June 30, 2027
Swap terminates April 14, 2031; Bank of America is counterparty and Administrative Agent under the credit agreement
The Trustee issued a release answering Unit Holder questions about administrative expenses, a 2017–2020 joint interest audit adjustment, Hilcorp capital spending, and liquidity. It states general and administrative expenses fell by about $976,000 year over year, mainly due to costs from the 2024 trustee transition that did not recur, and that the $2,000,000 Texas Bank credit facility, maturing May 21, 2027, is being discussed for extension, renewal, or replacement.
General and administrative expenses decreased by approximately $976,000 year over year, mainly from non-recurring 2024 trustee transition costs
Outstanding principal on the $2,000,000 Texas Bank Line of Credit was approximately $1,075,400 as of September 18, 2026; the facility matures May 21, 2027
The Trustee is in talks with Texas Bank and evaluating other financing sources, including other commercial lenders, Unit Holders, and private lenders
National newswire distribution of monthly press releases will be restored, beginning with the October 2026 release
Greenland Mines Ltd. agreed on September 28, 2026 to sell 1,320,000 shares of common stock in a direct registered offering to institutional investors, with expected net proceeds of about $17.2 million. The offering is expected to close on or about September 29, 2026, and the company plans to use the proceeds with existing cash for its Greenland mining operations and general working capital, which would add new shares outstanding and dilute existing holders.
1,320,000 shares of common stock offered; expected net proceeds of about $17.2 million after offering expenses
Expected closing on or about September 29, 2026, subject to customary closing conditions
On September 23, 2026, the company terminated its August 24, 2026 at-the-market sales agreement with A.G.P./Alliance Global Partners, under which $1,388,827.04 of shares had been sold
Wintergreen Acquisition Corp. issued a $184,635 non-interest-bearing promissory note to its sponsor, MACRO DREAM Holdings Limited, to fund a deposit into its trust account for an extension. The board approved extending the deadline for completing its business combination with KIKA Technology Inc. from September 30, 2026 to October 30, 2026, and the company says it continues to pursue that deal.
Note principal of $184,635 issued September 28, 2026 to sponsor MACRO DREAM Holdings Limited
Business combination deadline extended from September 30, 2026 to October 30, 2026
Sponsor may convert unpaid note principal into units at $10.00 per unit upon a business combination
Note is forgiven and the sponsor waives trust account claims if no business combination is completed
Ready Capital Corporation said its subsidiary ReadyCap Holdings II closed a private placement of $225.0 million of 10.00% senior secured notes due 2031 on September 28, 2026. On the same day, an indirect subsidiary redeemed the entire $350.0 million of its 4.50% senior secured notes due 2026 at 100% of principal plus accrued interest. The filing is a financing refinancing update and does not report revenue, earnings or guidance.
New Notes: $225.0 million aggregate principal, 10.00% coupon, due 2031, closed September 28, 2026
Existing Notes: entire $350.0 million 4.50% senior secured notes due 2026 redeemed September 28, 2026
Redemption price: 100% of principal amount plus accrued and unpaid interest
Offering was previously priced and disclosed in a Form 8-K filed September 18, 2026
OPENLANE's subsidiaries amended two receivables purchase facilities on September 25, 2026, extending the termination date of each from January 31, 2028 to January 31, 2030. The filing describes the extension as a term extension and does not mention new borrowing capacity, pricing changes, or costs.
U.S. facility: Second Amendment to the Tenth Amended and Restated Receivables Purchase Agreement, signed September 25, 2026, extends termination date to January 31, 2030
Canadian facility: Amendment No. 4 to the Receivables Purchase Agreement dated March 1, 2023, signed September 25, 2026, extends termination date to January 31, 2030
Full amendment texts will be filed as exhibits to the Form 10-Q for the quarter ended September 30, 2026
Voyager Technologies issued $402.5 million of 0% convertible senior notes due October 15, 2032, on September 28, 2026, including $52.5 million from the initial purchasers' full option exercise. The company reported net proceeds of approximately $391.6 million and plans to use about $52.5 million to fund capped call transactions, with the rest for general corporate purposes. Holders can convert into cash, Class A common stock, or a mix, which could dilute existing shareholders if the notes are converted into shares.
Principal: $402.5 million, including $52.5 million from the full exercise of the initial purchasers' option
Initial conversion price of approximately $40.82 per share, a premium of about 30% over the $31.40 close on September 23, 2026
Capped calls have a cap price of $78.50 per share and cost approximately $52.5 million
Net proceeds of approximately $391.6 million; the notes mature October 15, 2032
ADARx Pharmaceuticals closed its initial public offering on September 28, 2026, selling 26,250,000 shares at $17.00 each for approximately $446.3 million in gross proceeds. AbbVie bought 5,255,542 shares in a concurrent private placement for approximately $89.3 million in gross proceeds, leaving it with about 4.9% of outstanding common stock after the closings. The company also adopted an amended and restated certificate of incorporation and bylaws in connection with the IPO.
IPO closed September 28, 2026: 26,250,000 shares at $17.00 per share, approximately $446.3 million in gross proceeds.
AbbVie bought 5,255,542 shares in a private placement at the IPO price, approximately $89.3 million in gross proceeds, owning about 4.9% after closing.
Placement agent fee was 2.0% of the private placement purchase price; J.P. Morgan, Morgan Stanley, TD Securities, UBS and LifeSci Capital acted as agents.
Amended and restated certificate of incorporation and bylaws took effect September 28, 2026.
Churchill Downs closed an amendment to its senior secured credit agreement that extends its revolving credit facility and Term Loan A from 2029 to 2031. It also closed a new $500 million senior secured Term Loan B due 2033, which the company plans to use to repay existing term loan and revolver borrowings, fund fees, and for general corporate purposes. The filing does not report earnings or guidance, so its effect on shareholders depends on the terms of the new debt.
Revolver and Term Loan A maturities extended from 2029 to September 25, 2031
New $500 million Term Loan B due September 25, 2033, at SOFR plus 175 basis points, issued at 99.875% of principal
Net proceeds to repay term loan B-1 and revolving loans, pay fees and expenses, and for working capital
Company plans to fund redemption of its 5.50% Senior Notes due 2027 on October 19, 2026 from the revolver
Burke & Herbert Financial Services Corp. filed a preliminary prospectus supplement for a proposed $100 million offering of fixed-to-floating rate subordinated notes due 2036, under an existing shelf registration. The company plans to use the proceeds, plus cash on hand, to redeem up to $117.6 million of outstanding subordinated debt and up to $15.0 million of preferred stock, with the remainder for general corporate purposes, including capital for its bank.
Proposed offering size is $100 million; the notes have a 10-year term with a 5-year call, and Keefe, Bruyette & Woods is sole manager.
Expected rating is BBB- (Positive) from Kroll Bond Rating Agency.
Proceeds plus cash on hand would redeem up to $117.6 million of subordinated debt and up to $15.0 million of preferred stock liquidation preference.
Filing is dated September 28, 2026; the shelf registration was declared effective December 11, 2024, and an investor presentation is filed as Exhibit 99.1.
Hut 8 Corp. entered into a $1.07 billion senior secured revolving credit facility with JPMorgan Chase Bank, N.A. as administrative agent, dated September 24, 2026, with no amounts outstanding at closing. The company says the facility adds committed parent-level liquidity for interim working capital and letter of credit needs, which it describes as a way to fund projects while it decides on longer-term non-recourse financing.
Facility size: up to $1,070.0 million, including a $1,070.0 million letter of credit sublimit; matures on the fourth anniversary of the September 24, 2026 closing date
Initial margin of 1.750% per annum for Term SOFR loans, within a range of 1.50% to 2.00%, based on the company's debt-to-market-capitalization ratio
Minimum liquidity covenant begins with the quarter ending March 31, 2027, at 40% of commitments before the Stabilization Date and 25% after
BOXABL entered into an ATM Sales Agreement on September 25, 2026, allowing it to sell up to $100 million of its Class A common stock through six sales agents. The company has no obligation to sell any shares and may suspend offers at any time, but any sales would add to the number of shares outstanding.
Aggregate sales price of up to $100 million of Class A common stock through agents Virtu Americas, A.G.P./Alliance Global Partners, Cohen & Company Capital Markets, Maxim Group and Roth Capital Partners
Each agent may receive a commission of up to 3.0% of gross proceeds, and BOXABL agreed to reimburse agent fees and expenses up to $75,000
Shares will be sold under a Form S-3 shelf registration filed July 27, 2026 and declared effective August 10, 2026, with a prospectus supplement filed September 25, 2026
Either side may terminate on three days' prior notice
Stepan entered into a new Credit Agreement on September 25, 2026, providing $500.0 million in initial committed facilities: a $350.0 million multicurrency revolver and a $150.0 million delayed draw term loan, both maturing September 25, 2031. The new facilities replace its $350.0 million revolver and $100.0 million delayed draw term loan under a June 24, 2022 agreement, and include an option for up to an additional $250.0 million, giving the company expanded, longer-dated borrowing capacity.
Initial facilities total $500.0 million: $350.0 million revolver and $150.0 million delayed draw term loan, both maturing September 25, 2031
Replaces the $350.0 million revolver and $100.0 million delayed draw term loan from a June 24, 2022 credit agreement
Expansion option allows up to an additional $250.0 million, subject to certain requirements
Loans priced at spreads of 1.125% to 1.625% over term benchmark rates, depending on net leverage ratio; covenants include interest coverage and net leverage ratios
Tidewater Inc. entered into a Guarantee Agreement with Brazil's BNDES on September 21, 2026, agreeing to guarantee full and timely payment of its subsidiary's obligations under five BNDES construction loans. The filing states the guarantee is unsecured and ranks pari passu with Tidewater's other unsecured and unsubordinated obligations, and that the company is working with BNDES to release Wilson Sons and Remolcadores as guarantors.
Guarantee dated September 21, 2026, covers obligations of Wilson Sons Offshore S.A. (now Tidewater do Brasil S.A.) as borrower
Covers five BNDES Construction Loans entered into between 2007 and 2012, under Credit Facility Agreements Nos. 07.2.0417.1 through 12.2.0434.1
Guarantee is unsecured and ranks pari passu with Tidewater's other unsecured, unsubordinated obligations
Filing does not state a loan amount; Tidewater is working with BNDES to finalize release of Wilson Sons and Remolcadores as guarantors
On September 22, 2026, Healthcare Triangle entered into a First Amendment to its June 12, 2026 Equity Purchase Agreement with Hudson Global Ventures, LLC. The amendment lowers the maximum amount that can be sold under each Put Notice from $2.5 million to $250,000 and raises the minimum price per share from $0.01 to $0.10, while adding a provision that ends the company's right to deliver Put Notices after a Change of Control Transaction.
Maximum amount per Put Notice reduced from $2.5 million to $250,000 under Section 2.1
Minimum price per share raised from $0.01 to $0.10, subject to adjustments for splits and similar events
After a Change of Control Transaction, the company no longer has the right to deliver any Put Notice
Amendment dated September 22, 2026; original agreement filed as Exhibit 10.2 to the June 15, 2026 8-K
CleanSpark's subsidiary CSDC Finance I, LLC closed a private offering of $2.276 billion in 7.875% senior secured notes due October 1, 2031, priced at 98.500% of principal. Proceeds are intended to finance the remaining cost of the Sandersville Facility, a Georgia data center, reimburse prior equity contributions, and fund debt service reserves. The notes are secured obligations of the issuer, and CleanSpark has agreed to a completion guarantee for the facility if funding falls short.
Principal of $2,276.0 million sold at 98.500% of par, with interest of 7.875% per year paid semiannually from April 1, 2027
Notes mature October 1, 2031; issuer may redeem on or after October 1, 2028, with a make-whole premium before that date
Indenture limits additional debt, dividends, asset sales and affiliate transactions; change of control triggers an offer to repurchase at 101% of principal
CleanSpark will provide a completion guarantee for the Sandersville Facility, funding the issuer if proceeds and prior equity contributions are insufficient
DICK'S Sporting Goods agreed on September 22, 2026 to sell $1 billion of senior notes to underwriters, with the notes issued under a prospectus supplement filed September 23, 2026. The company says it will use the net proceeds for general corporate purposes, which may include debt repayment, share repurchases and future acquisitions, and the notes are not guaranteed by its subsidiaries.
$400 million of 6.200% senior notes mature September 25, 2036
$600 million of 6.900% senior notes mature September 25, 2056
Notes are unsecured and not guaranteed by subsidiaries, so they are structurally subordinated to subsidiary liabilities
Net proceeds may fund operations, debt repayment, share repurchases and acquisitions
Dynatrace's subsidiaries signed a Credit Agreement with Bank of America, N.A. as administrative agent for a $500 million senior secured revolving credit facility. The facility matures June 24, 2031, and carries leverage-based pricing and a maximum Total Leverage Ratio covenant of 4.00 to 1.00.
Revolving commitments of up to $500 million, signed September 24, 2026 with Bank of America, N.A. as administrative agent
Non-U.S. dollar borrowings in Euros, Pounds Sterling and Canadian Dollars are capped at $100 million in aggregate
Facility matures June 24, 2031, with a springing maturity tied to the 2031 exchangeable notes if more than $300 million remain outstanding 91 days before their maturity
Leverage covenant of 4.00 to 1.00 starts with the fiscal quarter ending December 31, 2026, temporarily rising to 4.50 to 1.00 after certain acquisitions over $150 million
Dynex Capital agreed on September 22, 2026 to sell 4,800,000 shares of 9.375% Series D Fixed-Rate Cumulative Redeemable Preferred Stock in an underwritten public offering. The company expects net proceeds of about $116.2 million and plans to use them to finance the acquisition of Agency and other investment securities and for general corporate purposes. For shareholders, the offering adds preferred equity to the capital structure, and the filing states the company intends to list the new shares on the NYSE as DXPRD.
4,800,000 shares at a $25.00 liquidation preference per share, for expected gross proceeds of $120 million before discounts and expenses
Expected net proceeds of approximately $116,220,000, before estimated expenses and assuming no exercise of the underwriters' option
Underwriters hold a 30-day option to buy up to 720,000 additional shares
Expected closing on or about September 29, 2026; intended NYSE listing under the symbol DXPRD
Artisan Partners Holdings LP entered a $150 million five-year revolving credit agreement with Bank of America as administrative agent, maturing September 23, 2031, and terminated its prior $100 million facility. No borrowings were outstanding under either facility, so the change adds available credit rather than new debt.
New $150 million revolving facility dated September 23, 2026, with commitments increasable up to $225 million
Matures September 23, 2031; replaces $100 million facility dated August 16, 2022, which was set to mature August 16, 2027
Borrowings priced at Term SOFR plus 1.25% to 2.00%, depending on leverage ratio; covenants cap leverage at 3.00 to 1.00 and require interest coverage of at least 4.00 to 1.00
No outstanding borrowings under the new credit agreement as of the filing date
Enova's indirect subsidiary ODAS IV issued $500,026,000 of Series 2026-1 Fixed Rate Asset Backed Notes on September 25, 2026, secured by a pool of small business loans from OnDeck, another Enova subsidiary. OnDeck used substantially all the proceeds for loan purchases from its affiliates and for general corporate purposes. The filing does not address earnings, and the notes are non-recourse to Enova and OnDeck, so the direct effect on shareholders is not stated.
Series 2026-1 Notes were issued in four classes (A through D) with a weighted average fixed coupon of 6.22% per annum.
Class A is $235,275,000 at 5.61%; Class D is $55,372,000 at 8.28%.
Revolving period ends September 2028; final maturity is October 2032; optional prepayment begins October 2027.
Loan pool was approximately $526 million at issuance; Deutsche Bank Trust Company Americas is indenture trustee and Kroll Bond Rating Agency rated the notes.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.